Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369160 · ClinicalTrials.gov registry record
Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 33
- Enrollment target
NCT01369160: Completed study, sponsored by Emory University.
NCT01369160 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 33 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01369160 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 33 participants
- Enrollment target
Study Summary
The research proposed is a pilot study of pediatric and adolescent/young adult patients who have received the curative intervention (MSD-SCT), disease-modifying interventions (HU or CT) or SCC (control), with respect to three clinically important outcomes: quality-of-life (QOL), neurocognitive function, and reproductive potential. Comparable cohorts will be identified for each of the groups, drawing from patients treated by the SCD program of Children's Healthcare of Atlanta (CHOA). QOL measures and neuropsychiatric testing and will be administered. Reproductive endocrine function markers (laboratory studies and pubertal staging), will be collected and analyzed. A tracking system of such patients will also be developed, gathering available retrospective data and setting up a mechanism for collection of new data.
Interventions
- BEHAVIORAL Quality of Life measures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2005-05 |
| Est. Completion | 2014-03 |
What the finished NCT01369160 record still lists
NCT01369160 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 33 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Quality of Life measures is the first listed.
NCT01369160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01369160 about?
NCT01369160 is a clinical study titled "Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease". The research proposed is a pilot study of pediatric and adolescent/young adult patients who have received the curative intervention (MSD-SCT), disease-modifying interventions (HU or CT) or SCC (control), with respect to three clinically important outcomes: quality-of-life (QOL), neurocognitive funct...
What is the current status of trial NCT01369160?
This trial is currently completed. The enrollment target is 33 participants. The study started on 2005-05. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01369160?
The interventions under investigation include: Quality of Life measures (BEHAVIORAL).
Who is sponsoring clinical trial NCT01369160?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia